In 2024, thin was in, and it’s partly thanks to the diabetic treatment GLP-1, which has become more known for its rapid weight loss benefits.
Glucagon-like peptide-1, more commonly referred to as GLP-1, first hit the market in 2017 when the FDA approved Ozempic. Since then, other versions, including Wegovy in 2021 and Mounjaro in 2022, have also rolled out to the public.
Though these medications are not new, weight-loss-focused trends (like 75 hard, time-restricted eating and alternate-day fasting) and, inadvertently, the increased education and awareness around women’s health have played significant roles in the category’s meteoric rise this year.
Continue reading this article on glossy.co. Sign up for Glossy newsletters to get the latest on the business of beauty, fashion and pop culture.